 Norwood, MA, Nov. 10, 2020 GLOBE NEWSWIRE -- Corbus Pharmaceuticals Holdings, Inc. NASDAQ: CRBP Corbus or the Company, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system ECS, today reported financial results for the third quarter of 2020. The Company also provided clinical, pipeline and corporate updates. 